-The Times of India With the state budget all set to be presented on July 12, TOI takes a hard look at the government's cheap rice scheme and its impact on politics and employment. Will cheap rice boil? Let's look at the math. Reducing the price from Rs 3 to Re 1 per kg will help a family save Rs 60 per month. Till now, poor families got rice from the Public Distribution...
More »SEARCH RESULT
Total Matching Records found : 1104
Policymakers need to create more opportunities for small farmers, UN report
-The United Nations Small-scale farmers - who produce the majority of food in the developing world - need to be better integrated into markets to reduce global hunger and poverty, the United Nations food and agricultural agency today reported urging more nuanced policymaking for smallholder farmers. "Policy interventions that aim at encouraging greater levels of smallholder production for sale in markets need to take better account of the heterogeneity of smallholder households,"...
More »The kidney paradox
-The Hindu Chronic corruption and lack of affordable access to treatments for serious diseases in the public health system stand exposed in the kidney commerce scandal in Tamil Nadu's Dharmapuri district. Nothing can be a greater irony than the existence of such thriving sale of organs in a State that also has perhaps the best-run programme for donation of kidneys, livers, hearts and lungs by deceased donors. It is no small...
More »No Country For Countrymen -Arun Sinha
-Outlook As the Manmohan Singh government makes evident its unfriendliness to villages, the nation hurtles towards disaster. It's a danger no one wants to face. Prime Minister Manmohan Singh has been trying for years to make us believe that agriculture is a vast marshland in which a huge population is stuck ankle- to neck-deep and it is his duty to rescue them. "Our salvation lies in moving people out of agriculture," he...
More »We trust indian manufacturing norms: USFDA -Divya Rajagopal
-The Economic Times MUMBAI: The United States Food and Drug Administration (USFDA), widely considered the world's most stringent regulatory authority, has said India's share in generic exports to the US over the years is an indication of the good manufacturing norms practised by Indian drugmakers. As the Ranbaxy scandal threatens to tarnish India's image as a hub of manufacturing world-class generic drugs, the statement, by USFDA's spokesman Chris Kelly in an...
More »
